August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension
0:00
8:54
Two highlighted clinical studies: the first addresses the effect of combining a SGLT2 inhibitor and a MRA on proteinuria; the second considers vascular reactivity as a risk factor for cerebral hypoxia when blood pressure falls during dialysis treatments.
More episodes from "Journal of the American Society of Nephrology (JASN)"
Don't miss an episode of “Journal of the American Society of Nephrology (JASN)” and subscribe to it in the GetPodcast app.